多重検出免疫測定法市場：技術、アッセイタイプ、用途、エンドユーザー別-2025-2030年世界予測

多重検出免疫測定法市場は、2023年に21億1,000万米ドルと評価され、2024年には22億5,000万米ドルに達すると予測され、CAGR 6.92%で成長し、2030年には33億7,000万米ドルに達すると予測されています。

多重検出免疫測定法は、1つのサンプルで複数の分析物を同時に同定・定量できる高度な診断技術であり、コストとサンプル消費量を削減しながらスループットを向上させることで、従来のアッセイよりも大きなメリットを提供します。これらのアッセイの必要性は、迅速かつ包括的な分析が重要である臨床診断、医薬品開発、環境検査、食品安全など、様々な分野での応用によってもたらされます。これらの技術のエンドユーザーには、病院、研究機関、製薬会社、診断研究所などが含まれます。市場成長の主な要因は、慢性疾患や感染症の増加、ゲノムおよびプロテオミクス研究の進歩、個別化医療の推進であり、これらすべてが革新的な診断ツールを必要としています。最新の潜在的機会は、新興市場におけるマルチプレックスアッセイの使用拡大と、データ管理と患者の転帰を改善するためのデジタルヘルス技術との統合にあります。しかし、高額な装置、複雑なアッセイ開発、厳しい規制要件といった要因が大きな課題となっています。さらに、高度なシステムの操作には熟練した人材が必要であり、これがまた複雑さを増しています。このような障害を克服するために、企業はアッセイ法の設計と操作の簡素化を目指した技術革新に投資することができます。研究開発分野としては、低存在量のバイオマーカーの検出を可能にする、より堅牢なプラットフォームの開発や、データ解釈を強化するためのAIや機械学習との統合などが考えられます。市場競争は激しく断片化されており、大手企業は提携、共同研究、買収を通じてポートフォリオの拡大を常に模索しています。こうした課題を戦略的に乗り越え、継続的なイノベーションとコラボレーションに注力することで、企業はこの分野の大きな成長ポテンシャルを活用し、市場での地位を高め、長期的な成功を確保することができます。

市場力学：急速に進化する多重検出免疫測定法市場の主要市場インサイトを公開

多重検出免疫測定法市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性・感染症罹患率の上昇
  • 個別化された精密医薬品への嗜好の高まり
  • 医薬品開発と研究活動に対する政府からの有利な資金援助
• 市場抑制要因
  • 装置の複雑さと高コスト
• 市場機会
  • ヘルスケアおよび製薬業界における先端技術の出現
  • 臨床診断における自動化機器の急速な発展
• 市場の課題
  • 熟練した経験豊富な専門家の不足

ポーターのファイブフォース多重検出免疫測定法市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：多重検出免疫測定法市場における外部からの影響の把握

外部マクロ環境要因は、多重検出免疫測定法市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析多重検出免疫測定法市場における競合情勢の把握

多重検出免疫測定法市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス多重検出免疫測定法市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、多重検出免疫測定法市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨多重検出免疫測定法市場における成功への道筋を描く

多重検出免疫測定法市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患や感染症の発生率が上昇
    • パーソナライズされた精密医療への関心の高まり
    • 医薬品開発および調査活動に対する政府の有利な資金援助
  • 抑制要因
    • 関連する複雑さと機器の高コスト
  • 機会
    • ヘルスケアおよび製薬業界における先進技術の出現
    • 臨床診断における自動化機器の急速な発展
  • 課題
    • 熟練した経験豊富な専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 多重検出免疫測定法市場：技術別

• バイオセンサーベースの技術
• 核酸ベースの技術
• タンパク質ベースの技術

第7章 多重検出免疫測定法市場アッセイタイプ別

• 抗体アレイ
• ビーズベースのアッセイ
• ブレンドタンパク質アレイ（マルチプレックスELISA）
• 磁気ビーズベース
• 非磁性ビーズベース
• 平面アッセイ

第8章 多重検出免疫測定法市場：用途別

• 病気の検査
• 食品汚染検査
• 研究開発
• 獣医疾患検査

第9章 多重検出免疫測定法市場：エンドユーザー別

• 学術調査機関
• バイオテクノロジー企業
• 臨床調査機関
• 診断センター
• 食品・飲料会社
• 製薬会社

第10章 南北アメリカの多重検出免疫測定法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の多重検出免疫測定法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの多重検出免疫測定法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam PLC
• Advanced Cell Diagnostics, Inc.
• Aehealth Limited
• Assay Genie
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories
• Elabscience Biotechnology Inc.
• Fortis Life Sciences LLC
• Illumina Inc.
• Luminex Corporation by DiaSorin S.p.A.
• Merck KGaA
• Meso Scale Diagnostics, LLC
• PerkinElmer Inc.
• Promega Corporation
• Qiagen N.V.
• Quansys Biosciences Inc.
• Quanterix Corporation
• R&D Systems, Inc.
• Randox Laboratories Ltd.
• Sartorius AG
• Scienion by Bico Company
• Scorpius BioManufacturing
• Seegene Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MULTIPLEX DETECTION IMMUNOASSAYS MARKET DYNAMICS
• TABLE 7. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOSENSOR-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PROTEIN-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ANTIBODY ARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BEAD-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BLENDS PROTEIN ARRAYS (MULTIPLEXED ELISA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY NON-MAGNETIC BEAD-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PLANAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD CONTAMINATION TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY VETERINARY DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY FOOD & BEVERAGES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. CHINA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 70. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. INDIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 139. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. ITALY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 155. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. POLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 159. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. QATAR MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM MULTIPLEX DETECTION IMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. MULTIPLEX DETECTION IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 199. MULTIPLEX DETECTION IMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

The Multiplex Detection Immunoassays Market was valued at USD 2.11 billion in 2023, expected to reach USD 2.25 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 3.37 billion by 2030.

Multiplex Detection Immunoassays are advanced diagnostic techniques that allow the simultaneous identification and quantification of multiple analytes in a single sample, offering substantial benefits over traditional assays by increasing throughput while reducing costs and sample consumption. The necessity of these assays is driven by their application across various sectors including clinical diagnostics, drug development, environmental testing, and food safety, where rapid and comprehensive analysis is critical. End-users of these technologies encompass hospitals, research institutions, pharmaceutical companies, and diagnostic laboratories. Market growth is primarily influenced by the increasing prevalence of chronic and infectious diseases, advancements in genomic and proteomic research, and the push for personalized medicine, all demanding innovative diagnostic tools. The latest potential opportunities lie in expanding the use of multiplex assays in emerging markets and integrating them with digital health technologies to improve data management and patient outcomes. However, factors such as the high cost of equipment, complex assay development, and stringent regulatory requirements pose significant challenges. Furthermore, a need for skilled personnel to operate sophisticated systems adds another layer of complexity. To overcome these obstacles, companies can invest in technological innovation aimed at simplifying assay design and operations, which can lower costs and broaden accessibility. Areas of research could include the development of more robust platforms that allow for the detection of low-abundance biomarkers or integration with AI and machine learning for enhanced data interpretation. The market is highly competitive and fragmented, with major players constantly seeking to expand their portfolios through partnerships, collaborations, and acquisitions. By strategically navigating these challenges and focusing on continuous innovation and collaboration, businesses can tap into the significant growth potential in this field, thereby enhancing their market position and ensuring long-term success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiplex Detection Immunoassays Market

The Multiplex Detection Immunoassays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of chronic and infectious diseases across the globe
  • Growing preference for personalized -precision medicines
  • Favorable government funding for drug development and research activities
• Market Restraints
  • Associated complexity and high cost of equipment
• Market Opportunities
  • Emergence of advanced technologies in the healthcare and pharmaceutical industry
  • Rapid development of automated instruments in clinical diagnostics
• Market Challenges
  • Dearth of skilled and experienced subject matter experts

Porter's Five Forces: A Strategic Tool for Navigating the Multiplex Detection Immunoassays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiplex Detection Immunoassays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiplex Detection Immunoassays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiplex Detection Immunoassays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiplex Detection Immunoassays Market

A detailed market share analysis in the Multiplex Detection Immunoassays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiplex Detection Immunoassays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiplex Detection Immunoassays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiplex Detection Immunoassays Market

A strategic analysis of the Multiplex Detection Immunoassays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiplex Detection Immunoassays Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Advanced Cell Diagnostics, Inc., Aehealth Limited, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories, Elabscience Biotechnology Inc., Fortis Life Sciences LLC, Illumina Inc., Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Meso Scale Diagnostics, LLC, PerkinElmer Inc., Promega Corporation, Qiagen N.V., Quansys Biosciences Inc., Quanterix Corporation, R&D Systems, Inc., Randox Laboratories Ltd., Sartorius AG, Scienion by Bico Company, Scorpius BioManufacturing, Seegene Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiplex Detection Immunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technique, market is studied across Biosensor-Based Techniques, Nucleic Acid-Based Techniques, and Protein-Based Techniques.
• Based on Assay Type, market is studied across Antibody Arrays, Bead-based assay, Blends Protein Arrays (Multiplexed ELISA), Magnetic Bead-based, Non-magnetic Bead-based, and Planar Assay.
• Based on Application, market is studied across Disease Testing, Food Contamination Testing, Research and Development, and Veterinary Disease Testing.
• Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Clinical Research Organizations, Diagnostic Centers, Food & Beverages Companies, and Pharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of chronic and infectious diseases across the globe
    • 5.1.1.2. Growing preference for personalized -precision medicines
    • 5.1.1.3. Favorable government funding for drug development and research activities
  • 5.1.2. Restraints
    • 5.1.2.1. Associated complexity and high cost of equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of advanced technologies in the healthcare and pharmaceutical industry
    • 5.1.3.2. Rapid development of automated instruments in clinical diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled and experienced subject matter experts
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Multiplex Detection Immunoassays Market, by Technique

• 6.1. Introduction
• 6.2. Biosensor-Based Techniques
• 6.3. Nucleic Acid-Based Techniques
• 6.4. Protein-Based Techniques

7. Multiplex Detection Immunoassays Market, by Assay Type

• 7.1. Introduction
• 7.2. Antibody Arrays
• 7.3. Bead-based assay
• 7.4. Blends Protein Arrays (Multiplexed ELISA)
• 7.5. Magnetic Bead-based
• 7.6. Non-magnetic Bead-based
• 7.7. Planar Assay

8. Multiplex Detection Immunoassays Market, by Application

• 8.1. Introduction
• 8.2. Disease Testing
• 8.3. Food Contamination Testing
• 8.4. Research and Development
• 8.5. Veterinary Disease Testing

9. Multiplex Detection Immunoassays Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Biotechnology Companies
• 9.4. Clinical Research Organizations
• 9.5. Diagnostic Centers
• 9.6. Food & Beverages Companies
• 9.7. Pharmaceutical Companies

10. Americas Multiplex Detection Immunoassays Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Multiplex Detection Immunoassays Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Multiplex Detection Immunoassays Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Advanced Cell Diagnostics, Inc.
• 3. Aehealth Limited
• 4. Assay Genie
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Charles River Laboratories
• 8. Elabscience Biotechnology Inc.
• 9. Fortis Life Sciences LLC
• 10. Illumina Inc.
• 11. Luminex Corporation by DiaSorin S.p.A.
• 12. Merck KGaA
• 13. Meso Scale Diagnostics, LLC
• 14. PerkinElmer Inc.
• 15. Promega Corporation
• 16. Qiagen N.V.
• 17. Quansys Biosciences Inc.
• 18. Quanterix Corporation
• 19. R&D Systems, Inc.
• 20. Randox Laboratories Ltd.
• 21. Sartorius AG
• 22. Scienion by Bico Company
• 23. Scorpius BioManufacturing
• 24. Seegene Inc.
• 25. Thermo Fisher Scientific Inc.